Transcode Therapeutics Inc (RNAZ) — Defensive Interval Ratio
Transcode Therapeutics Inc (RNAZ) has a Defensive Interval Ratio of 0 days as of June 2026. Defensive assets of $638.00 (cash $-, short-term investments $-, receivables $638.00) cover 0 days of daily cash needs of $14.79K/day. See Transcode Therapeutics Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Transcode Therapeutics Inc Defensive Interval Ratio (2020–2025)
This chart shows how Transcode Therapeutics Inc's Defensive Interval Ratio has evolved across 4 annual periods from 2020 to 2025. As of June 2026, the ratio stands at 0 days, meaning defensive assets of $638.00 can fund 0 days of operations without new revenue. Read Transcode Therapeutics Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for Transcode Therapeutics Inc (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Transcode Therapeutics Inc from 2020 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Transcode Therapeutics Inc balance sheet assets.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 340 days | $3.25 Million | $9.57K/day | $- | $- | ▲ +309 days |
| 2022 | 31 days | $369.64K | $11.91K/day | $- | $9.41K | ▲ +31 days |
| 2021 | 0 days | $9.41 | $6.94K/day | $- | $9.41 | ▼ 0 days |
| 2020 | 0 days | $3.20 | $1.11K/day | $- | $3.20 | — |